Silk Road Medical

Develops and manufactures less-invasive medical devices to improve the treatment of vascular disease through proprietary transcarotid therapies.

Launch date

2007

Employees

Market cap

Enterprise valuation

AUD1.6b (Public information from Sep 2024)

Sunnyvale California (HQ)

http://silkroadmed.com

https://twitter.com/silkroadmed https://www.linkedin.com/company/silk-road-med

View job openings

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	75.2m	101m	139m	177m	199m	220m	243m
% growth	19 %	35 %	37 %	28 %	13 %	11 %	10 %
EBITDA	(41.8m)	(47.3m)	(49.7m)	(45.1m)	(14.4m)	(7.0m)	1.3m
% EBITDA margin	(56 %)	(47 %)	(36 %)	(25 %)	(7 %)	(3 %)	1 %
Profit	(47.4m)	(49.8m)	(55.0m)	(55.7m)	(55.1m)	(54.3m)	(50.8m)
% profit margin	(63 %)	(49 %)	(40 %)	(31 %)	(28 %)	(25 %)	(21 %)
EV / revenue	28.1x	14.0x	13.5x	2.1x	5.5x	4.8x	4.3x
EV / EBITDA	-50.7x	-30.1x	-37.8x	-8.3x	-75.7x	-152.5x	836.8x
R&D budget	21.3m	27.1m	36.4m	41.3m	-	-	-
R&D % of revenue	28 %	27 %	26 %	23 %	-	-	-

Date	Investors	Amount	Round
May 2007	The Vertical Group	$3.4m	Series A
Apr 2011	The Vertical Group	$8.2m	Series B
Apr 2012	The Vertical Group	$13.0m	Series B
Apr 2013	N/A	$17.0m	Series B
Aug 2014	N/A	$15.0m	Late VC
Oct 2015	Warburg Pincus The Vertical Group CRG LP	$57.0m	Late VC
Jul 2017	Warburg Pincus Norwest Venture Partners The Vertical Group Janus Capital Group	$47.0m	Series C
Apr 2019	N/A	N/A	IPO
Jan 2020	Armentum Partners	$50.0m	Debt
May 2022*	Oxford Finance	$250m	Post IPO Debt
Oct 2022*	N/A	$100m	Post IPO Equity
Jun 2024*	Boston Scientific	$1.2b Valuation: $1.2b	Acquisition
Total Funding		AUD248m

Tech stackLearn more about the technologies and tools that this company uses.